Professor Jamie Cavenagh is a Consultant (Honorary Senior Lecturer) in Haematology based at St Bartholomew's Hospital in Barts and The London NHS Trust. He qualified from St Mary's Hospital Medical School and went on to train in haematology at St George's Hospital, The Royal Marsden Hospital and Barts and The London. He was a Leukaemia Research Fund Scientific Training Fellow during which time he completed his MD thesis.

Professor Cavenagh's clinical and research interests are within haemato-oncology and bone marrow transplantation with particular emphasis on multiple myeloma, AML/MDS and allogeneic transplantation. He has published over 100 scientific papers and is an executive member of the UKMF and sits on the NCRI myeloma clinical trials group.

• Haemato-oncology
• Bone marrow transplantation
• Multiple myeloma
• AML/MDS
• Allogeneic transplantation

• Haemato-oncology
• Bone marrow transplantation
• Multiple myeloma
• AML/MDS
• Allogeneic transplantation

Dr Ben Carpenter is a Consultant Haematologist at UCLH specialising in Children's & Adolescent Services.

Dr Carpenter achieved his primary medical qualification (MB BS) in 2001 at University of London.

Primary immunodeficiency

HLH

Red Cell Gene therapy

• Teenagers and young adults- Haematology

Dr Parag Jasani is a Consultant Haematologist with an NHS practice at the Royal Free London NHS Trust and University College London Hospitals (UCLH).

Dr Jasani has expertise in a wide range of haematology conditions ranging from general haematology to blood cancers.

Dr Jasani treats patients with various blood disorders such as abnormal blood counts (anaemia, neutropenia, lymphopenia, thrombocytopenia, polycythemia, thrombocytosis), coagulation disorders (thrombosis, bleeding problems), and blood cancers (lymphoma, leukaemia, myeloma).

He has a special interest in Chronic Lymphocytic Leukaemia (CLL) and Lymphoma. At UCLH, Dr Jasani leads the CLL service. He is an author on London Cancer CLL guidelines. He gets asked to see complex CLL patients and second opinions, nationally and internationally.

He graduated in 2001 and he is fully registered with the General Medical Council. He has been on the GMC Specialist register since 2011. Dr Jasani completed his haematology training at Barts and The London NHS Trust in 2011.

Dr Jasani has special interest in research. He is a Principal investigator in various clinic trials and also collaborates very closely with international colleagues.

He believes in providing honest and highly professional advice. Dr Jasani works privately at HCA UK at University College London Hospitals. He is registered as a provider with all major UK insurance companies and is also happy to see uninsured self pay patients.

• Chemotherapy
• Iron infusion
• Venesection
• Bone marrow biopsy

• Abnormal blood counts
• Anaemia
• Neutropenia
• Lymphopenia
• Thrombocytopenia
• Polycythemia
• Thrombocytosis
• Coagulation disorders
• Thrombosis
• Bleeding problems
• Haematological cancers
• Lymphoma
• Leukaemia
• Myeloma
• Raised or reduced iron levels

Rachael Hough is a Consultant in Haematology and Stem Cell Transplantation at UCL Hospitals and an Honorary Senior Lecturer in Haematology/Transplantation at UCL.

After completing undergraduate training at Nottingham University in 1992, she undertook postgraduate general medical and haematology training in Sheffield. On achieving specialist accreditation, she was awarded a 2-year fellowship in the transplantation of umbilical cord blood. During this time, she gained specific experience in the management of paediatric and adolescent patients and spent 3 months working with Professor John Wagner, at the University of Minnesota, gaining specialist expertise in umbilical cord blood transplantation.

She is now the Clinical Lead of the largest teenage cancer service in the UK and has developed an adolescent-focussed transplant practice. She has also established and chairs the BSBMT Umbilical Cord Blood Working Group and is the Chief Investigator of the 2 NCRI-badged national cord blood transplant protocols.

• Leukaemia
• Acute lymphoblastic (ALL) and
• Haematological stem cell transplantation (HSCT, BMT) in young people